相关实验视频
Updated: Jun 11, 2025

08:09
A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish
Published on: June 7, 2018
9.7K
禁食:在对抗多克索鲁比诱导的心脏毒性的斗争中,一个复杂的,双刃的刀
Yiming Meng1, Jing Sun2, Guirong Zhang3
1Department of Central Laboratory, Cancer Hospital of Dalian University of Technology, Liaoning Cancer Hospital & Institute, No. 44, Xiaoheyan Road, Dadong District, Shenyang, 110042, China. cacamym@163.com.
Cardiovascular toxicology
|October 1, 2024
概括
禁食可能对健康有好处,但它对化疗的影响是复杂的. 研究表明,长时间的禁食可能会加剧常见的癌症药物多克索鲁比 (Dox) 的心脏损伤,需要谨慎.
科学领域:
- 心脏病学 心脏病学
- 在瘤学瘤学.
- 代谢健康 代谢健康
背景情况:
- 禁食对于改善胰岛素敏感性和减少炎症等健康益处越来越受欢迎.
- 多克索鲁比 (Dox) 是一种重要的化疗药物,但可以引起心脏毒性,导致心力衰竭.
- 禁食和Dox诱导的心脏毒性之间的相互作用需要彻底调查.
研究的目的:
- 在多克索鲁比诱导心脏毒性的背景下,研究禁食的潜在好处和缺点.
- 评估禁食如何影响心脏对化疗引起的心脏损伤的反应.
主要方法:
- 文献综述和对禁食和多克索鲁比辛现有研究的分析.
- 对化学疗法期间禁食影响的细胞和生理机制的研究.
主要成果:
- 在某些情况下,禁食可能会对Dox引起的心脏损伤产生保护作用.
- 新出现的证据表明,长时间的交替禁食可能会损害心脏处理Dox心脏毒性的能力.
- 禁食对Dox心脏毒性的整体影响是复杂的,并且取决于背景.
结论:
- 虽然禁食具有普遍的健康优势,但其与多克索鲁比治疗一起使用需要仔细考虑.
- 在接受多克索鲁比治疗的癌症患者中,必须承认禁食的潜在风险,特别是长期的形式.
- 进一步的研究至关重要,以澄清最佳的禁食协议,如果有的话,对于接受多克索鲁比化疗的患者.
相关概念视频
Heart Failure Drugs: Inotropic Agents
535
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
535
Exercise and Cardiovascular Response
745
Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
745
Cardiopulmonary Resuscitation IV: Pharmacological Management
2
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
2
Cardiomyopathy II: Dilated Cardiomyopathy
1
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
1
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
395
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
395
Cardiomyopathy VI: Nursing Management
2
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
2

